Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Taysha Gene Therapies (TSHA) Debt Ratio (2022 - 2025)

Taysha Gene Therapies (TSHA) has disclosed Debt Ratio for 4 consecutive years, with 0.15 as the latest value for Q4 2025.

  • Quarterly Debt Ratio fell 46.74% to 0.15 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.15 through Dec 2025, down 46.74% year-over-year, with the annual reading at 0.15 for FY2025, 46.74% down from the prior year.
  • Debt Ratio hit 0.15 in Q4 2025 for Taysha Gene Therapies, down from 0.16 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.91 in Q3 2023 to a low of 0.12 in Q2 2025.
  • Historically, Debt Ratio has averaged 0.3 across 4 years, with a median of 0.26 in 2024.
  • Biggest five-year swings in Debt Ratio: surged 169.95% in 2023 and later tumbled 73.93% in 2024.
  • Year by year, Debt Ratio stood at 0.3 in 2022, then dropped by 22.0% to 0.23 in 2023, then grew by 16.84% to 0.27 in 2024, then crashed by 46.74% to 0.15 in 2025.
  • Business Quant data shows Debt Ratio for TSHA at 0.15 in Q4 2025, 0.16 in Q3 2025, and 0.12 in Q2 2025.